These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 262739)

  • 1. [Thalassemia and HLA antigens].
    Kolevski P; Mladenovski B; Zisovski N; Ivanovski D; Nedelkovski J
    God Zb Med Fak Skopje; 1979 Jan; 25():289-94. PubMed ID: 262739
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA compatibility for patients with thalassemia: implications for bone marrow transplantation.
    Delfini C; Donati M; Marchionni D; Nesci S; Paradisi O; Valentini M; Nicolini G; Lucarelli G
    Int J Cell Cloning; 1986 Jul; 4(4):274-8. PubMed ID: 3528326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron overload in subjects with beta-thalassaemia trait: role of idiopathic haemochromatosis gene.
    Fargion S; Piperno A; Panaiotopoulos N; Taddei MT; Fiorelli G
    Br J Haematol; 1985 Nov; 61(3):487-90. PubMed ID: 3877523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histocompatibility antigens (HLA) on the erythrocytes of patients with beta-thalassemia major].
    Ragimov AA
    Gematol Transfuziol; 1988 Jul; 33(7):42-6. PubMed ID: 3181727
    [No Abstract]   [Full Text] [Related]  

  • 5. Independent segregation of HLA--A, --B and --C antigens from thalassemia minor.
    Parfrey PS; Turnbull AL; Wolf E; Sachs J; Festenstein H
    Tissue Antigens; 1979 May; 13(5):373-6. PubMed ID: 494226
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of HLA segregation in 479 thalassemic families.
    Contu L; Arras M; Mulargia M; La Nasa G; Carcassi C; Leone AL; Ledda A; Goddi F
    Tissue Antigens; 1992 Feb; 39(2):58-67. PubMed ID: 1574799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Outcomes in Young Class 3 Patients With Thalassemia Undergoing HLA-Identical Sibling Bone Marrow Transplantation.
    Gaziev J; Isgrò A; Sodani P; Marziali M; Paciaroni K; Gallucci C; De Angelis G; Andreani M; Testi M; Alfieri C; Ribersani M; Galluccio T; Battarra MR; Morrone A; Lucarelli G
    Transplantation; 2016 Apr; 100(4):925-32. PubMed ID: 26457600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic marrow transplantation for thalassemia.
    Lucarelli G; Polchi P; Izzi T; Manna M; Agostinelli F; Delfini C; Porcellini A; Galimberti M; Moretti L; Manna A
    Exp Hematol; 1984 Sep; 12(8):676-81. PubMed ID: 6386507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-A, B, C, and DR antigen frequencies in relation to development of diabetes and variations in white cell antibody formation in highly transfused thalassemia patients.
    Pollack MS; Levine LS; Oberfield SE; Markenson AL
    Transfusion; 1982; 22(4):279-82. PubMed ID: 6954755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are HLA antigens a risk factor for acute GVHD in thalassemic patients receiving HLA-identical stem cell transplantation?
    Mohyeddin Bonab M; Alimoghaddam K; Vatandoust S; Forouzia F; Jahani M; Ghavamzadeh A
    Transplant Proc; 2004 Dec; 36(10):3190-3. PubMed ID: 15686726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-mismatched bone marrow transplantation in thalassemia.
    Galimberti M; Lucarelli G; Polchi P; Angelucci E; Baronciani D; Politi P; Donati M; Filocamo M; Giorgi C; Agostinelli F
    Bone Marrow Transplant; 1991; 7 Suppl 3():98-100. PubMed ID: 1855100
    [No Abstract]   [Full Text] [Related]  

  • 12. Marrow transplantation for severe aplastic anemia and thalassemia major.
    Storb R; Anasetti C; Appelbaum F; Bensinger W; Buckner CD; Clift R; Deeg HJ; Doney K; Hansen J; Loughran T
    Semin Hematol; 1991 Jul; 28(3):235-9. PubMed ID: 1887251
    [No Abstract]   [Full Text] [Related]  

  • 13. HLA class I antibodies in thalassemic patients.
    Nathalang O; Torcharus K; Chuansumrit A; Punyaprasiddhi P; Sriphaisal T; Tatsumi N
    Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):801-4. PubMed ID: 10772568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study of HLA-ABCDR antigens in CML, ANLL, thalassemia and severe aplastic anemia in Thais.
    Chiewsilp P; Sujirachato K; Mongkolsuk T; Junpong S; Jootar S; Hathirat P
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S130-6. PubMed ID: 10865419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA histocompatibility antigens and meningococcal disease.
    Kristiansen BE; Thorsby E
    NIPH Ann; 1980 Dec; 3(2):75-9. PubMed ID: 7219842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune status in thalassemia major.
    Ballart IJ; Estevez ME; Muchinik G; Sen L
    Haematologica; 1988; 73(2):153. PubMed ID: 3137131
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenetic factors in thalassemia and hepatitis B infection. A multicentre study.
    Schanfield MS; Scalise G; Economidou I; Modell CB; Bate C; Zuckerman AJ
    Dev Biol Stand; 1975; 30():257-69. PubMed ID: 1204962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histocompatibility antigens in childhood myasthenia].
    Uhrynowska M
    Neurol Neurochir Pol; 1987; 21(2):119-24. PubMed ID: 3477704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemoglobin Indianapolis (beta 112[G14] arginine). An unstable beta-chain variant producing the phenotype of severe beta-thalassemia.
    Adams JG; Boxer LA; Baehner RL; Forget BG; Tsistrakis GA; Steinberg MH
    J Clin Invest; 1979 May; 63(5):931-8. PubMed ID: 447835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human leukocyte antigens (HLA) in children with insulin-dependent diabetes].
    Jokanović R; Nikezić M; Susaković N; Necić S; Radmanović S
    Srp Arh Celok Lek; 1981 Jul; 109(7):854-60. PubMed ID: 7048570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.